Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001213900-20-025532)

Filing Details

Accession Number:: 0001213900-20-025532
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-09-08 08:38:00
Reporting Period:: 2020-09-03

Accepted Time:: 2020-09-08 08:38:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1410098	Cormedix Inc.	CRMD	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1811612	T Matthew David	C/O Cormedix Inc. 400 Connell Drive, Suite 5000 Berkeley Heights NJ 07922	Chief Financial Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-09-03	1,150	$4.07	1,150	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (Right to Buy Common Stock)	$5.63		2030-05-11	125,000	125,000	Direct
Common Stock	Stock Option (Right to Buy Common Stock)	$4.08		2030-05-11	125,000	125,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2030-05-11	125,000	125,000	Direct
2030-05-11	125,000	125,000	Direct

Footnotes

These options were granted on 05/11/2020. 83,000 of these options vest annually over four years in four equal installments beginning 05/11/2021, subject to continued employment, and 42,000 of these options vest based on achievement of certain performance milestones, subject to continued employment through the applicable vesting date.